Ikarian Capital »

Alto Neuroscience shares owned by Ikarian Capital

Quarter-by-quarter ownership of Alto Neuroscience (ANRO) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Alto Neuroscience

Tip: Access up to 7 years of quarterly data

All positions including Alto Neuroscience held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alto Neuroscience by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $10M 881k 11.44

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Alto Neuroscience

Falcon Edge Capital
RA Capital Management
BlackRock
Franklin Resources
ExodusPoint Capital Management
Point72 Asset Management
Ikarian Capital
Jennison Associates
T. Rowe Price Associates
72 Investment Holdings
Vestal Point Capital
Vanguard Group
BlackRock
AWM Investment Company
Deep Track Capital

View all funds holding Alto Neuroscience